TY - JOUR
T1 - Renal Neuroendocrine Neoplasms
T2 - A Single-center Experience
AU - McGarrah, Patrick W.
AU - Westin, Gustavo F.M.
AU - Hobday, Timothy J.
AU - Scales, Joseph A.
AU - Ingimarsson, Johann P.
AU - Leibovich, Bradley C.
AU - Halfdanarson, Thorvardur R.
N1 - Funding Information:
The present study was supported by the National Center for Advancing Translational Sciences (grant UL1 TR002377 ). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
Funding Information:
T.R.H. declares research support from Ipsen, Thermo Fisher Scientific, Agios, and ArQule; consultancy (advisory boards) with Lexicon, Advanced Accelerator Applications, Novartis, and Curium. The remaining authors declare that they have no competing interests.The present study was supported by the National Center for Advancing Translational Sciences (grant UL1 TR002377). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2019
PY - 2020/8
Y1 - 2020/8
N2 - Renal neuroendocrine neoplasms are rare, with little to no data available on prognosis and treatment outcomes. We present the largest single-institution series of 17 patients, with a median follow-up of 62.8 months. After aggressive resection, the median time to recurrence was 18 months, and the median overall survival was 143 months. Somatostatin analogs provided disease stability in 4 of 9 patients.
AB - Renal neuroendocrine neoplasms are rare, with little to no data available on prognosis and treatment outcomes. We present the largest single-institution series of 17 patients, with a median follow-up of 62.8 months. After aggressive resection, the median time to recurrence was 18 months, and the median overall survival was 143 months. Somatostatin analogs provided disease stability in 4 of 9 patients.
KW - Horseshoe kidney
KW - Kidney carcinoid
KW - Rare cancers
KW - Renal carcinoid
KW - Renal neuroendocrine carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85077311764&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077311764&partnerID=8YFLogxK
U2 - 10.1016/j.clgc.2019.11.003
DO - 10.1016/j.clgc.2019.11.003
M3 - Article
C2 - 31911122
AN - SCOPUS:85077311764
SN - 1558-7673
VL - 18
SP - e343-e349
JO - Clinical Genitourinary Cancer
JF - Clinical Genitourinary Cancer
IS - 4
ER -